New cell therapy aims to shrink Hard-to-Treat cancers
Disease control
Not yet recruiting
This study tests a new cell therapy called SL-28 for people with advanced solid tumors that have not responded to standard treatments. The therapy uses donor immune cells to attack the cancer. The goal is to see if it is safe and can shrink tumors in up to 60 participants with va…
Phase: PHASE1, PHASE2 • Sponsor: Second Life Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:52 UTC